Apologies hit post too early. OD designation seems very unlikely. If they had a larger trial, and included hand-use, ambulation and removed Anxiety as a measure of efficacy they'd have better luck. Our P2 results weren't *that* strong but our trial design was less than ideal given GI issues, dosage and we've learnt how Daybue works in the real world (slowly increasing dosage) - and that the affect seems to compound with time.
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
Neuren Media and Analyst Coverage, page-1114
-
- There are more pages in this discussion • 231 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$13.51 |
Change
-0.300(2.17%) |
Mkt cap ! $1.751B |
Open | High | Low | Value | Volume |
$13.82 | $13.91 | $13.51 | $2.248M | 164.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1192 | $13.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.52 | 351 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 67 | 13.530 |
8 | 2916 | 13.520 |
3 | 1268 | 13.510 |
9 | 7893 | 13.500 |
7 | 420 | 13.490 |
Price($) | Vol. | No. |
---|---|---|
13.540 | 534 | 10 |
13.550 | 427 | 7 |
13.560 | 961 | 8 |
13.570 | 536 | 3 |
13.580 | 553 | 3 |
Last trade - 13.46pm 11/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |